A Prospective, One-arm and Open Clinical Study of Anti-CD38 Antibody in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
Condition: Antiphospholipid Syndrome With Secondary Thrombocytopenia Intervention: Drug: Anti-CD38 antibody Injection Sponsor: Institute of Hematology & Blood Diseases Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Antiphospholipid Syndrome | Hematology | Hospitals | Hughes Syndrome | Research | Study | Thrombocytopenia